Wall Street Zen Upgrades UnitedHealth Group to Buy

UnitedHealth Group (NYSE:UNH) has received a boost from Wall Street Zen, which upgraded its stock rating from 'hold' to 'buy'. This decision was made public in a research report issued on Saturday. The upgrade is not an isolated incident, as other analysts have also expressed similar views about the company's potential.

Bank of America recently reaffirmed its 'buy' rating for UnitedHealth Group, and Erste Group Bank raised its rating from 'hold' to 'buy'. DA Davidson set a price objective of $512.00 on the stock, while JPMorgan Chase & Co. increased its target price from $466.00 to $516.00 with an 'overweight' rating.

The upgrade by Wall Street Zen is part of a broader trend where analysts are increasingly optimistic about UnitedHealth Group's prospects. The company has seen significant growth in recent quarters, and its earnings have consistently exceeded expectations. In its latest quarterly report, UnitedHealth Group posted $6.38 earnings per share, beating analyst estimates of $4.94.